-
Roxadustat, sold
under the
brand name Evrenzo, is an anti-anemia medication.
Roxadustat is a HIF prolyl-hydroxylase
inhibitor that
increases endogenous...
- erythropoiesis-stimulating
agents (ESAs).
Several HIF-PHIs,
including roxadustat, daprodustat, vadadustat, molidustat, and enarodustat, have been approved...
- WTA history. In 2022,
Halep tested positive for the
banned substance roxadustat at the US Open and she was
given a four-year ban from the
sport in 2023...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
- prolyl-hydroxylase
inhibitors have been developed. The most
notable compounds are:
Roxadustat (FG-4592);
Vadadustat (AKB-6548),
Daprodustat (GSK1278863), Desidustat...
-
Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat Salbutamol/budesonide
Savolitinib Saxagliptin Sebelipase alfa Selumetinib...
